Diagnosis of Crimean-Congo haemorrhagic fever (CCHF) virus infections is hampered by the problems of handling this human pathogen, which requires the highest levels of biological containment. Recombinant antigens were examined for their potential as nonhazardous diagnostic reagents. The nucleocapsid (N) gene of the Greek AP92 isolate of CCHF virus was sequenced from cloned PCR products and the open reading frame was identified by homology to the N protein of a Chinese isolate of CCHF virus. The N protein was expressed to high levels in a baculovirus expression system. Three N protein-derived peptides were expressed in Eseherichia coli as fusions with glutathione S-transferase and the antigenicities of these proteins and the baculovirus-expressed protein were tested by ELISA. When tested with laboratory animal sera representing all seven serogroups of nairoviruses, the only reactive sera were those raised to CCHF virus (Greek, Nigerian and Chinese isolates) and, more weakly, Hazara virus. When tested with a panel of known positive and negative human sera, the baculovirus-expressed N protein, and the peptide derived from the central region of the N protein, proved to be the best for identifying CCHF virus-specific IgG.
Introduction
Crimean-Congo haemorrhagic fever (CCHF) virus is the type species of the genus Nairovirus (family Bunyaviridae). The virus is transmitted by a number of tick species and is widespread throughout southeastern Europe, Asia and Africa. In many countries CCHF virus causes a serious human disease with high mortality (Hoogstraal, 1979) . The disease has not yet been reported in Greece, but fatal cases have been reported from neighbouring countries (Albania, Bulgaria and the former Yugoslavia). However, the virus has been isolated from ticks in Greece (Papadopoulos & Koptopoulos, 1980) and serological surveys have shown human antibodies to CCHF virus, especially in woodcutters and farmers, who are likely to be exposed to the tick vector (Antoniadis et al., 1990) . Diagnosis currently relies on immunofluorescence of virus-infected cells or isolation of virus in suckling mouse brain. Both of these methods involve hazards to laboratory personnel as the CCHF virus is highly infectious, causing numerous nosocomial infections (Hoogstraal, 1979) , and is classified at the maximum level of containment. Previously, an ELISA The nucleotide sequence data in this paper have been deposited in GenBank and assigned the accession number U04958. system for certain nairoviruses was developed, based on the nucleoprotein of Dugbe (DUG) virus, a related nairovirus (Ward et al., 1992) . This antigen detected an unexpected prevalence of human nairovirus infections in Greece and Nigeria of 8 % and 20 % respectively, which were apparently not due to CCHF virus infections . The occurrence of these presumed subclinical nairovirus infections led us to develop a more specific and sensitive test to determine the prevalence of CCHF virus infection in human populations. Previously we have reported the nucleotide sequence of the S RNA segment of a Chinese isolate of CCHF virus . In this paper we describe the cloning and expression of the nucleoprotein (N) gene of a Greek CCHF isolate and the use of the expressed proteins in detecting anti-CCHF virus antibodies.
Methods
Viruses and antisera. CCHF virus isolate AP92 (Papadopoulos & Koptopoulos, 1980) was propagated in suckling mouse brain under appropriate containment conditions. Baculovirus bacPAK6 (Kitts & Possee, 1993) was obtained from Dr R. D. Possee (NERC Institute of Virology and Environmental Microbiology, Oxford, U.K.). Human sera were derived from a serological survey in Greece (Antoniadis et al., 1990) , or were obtained from the Centers for Disease Control, Atlanta, Ga., U.S.A. Laboratory animal sera prepared against a variety of nairoviruses have been described previously (Ward et al., 1992) . Peroxidase conjugates were purchased from Sigma.
PCR and cloning of CCHF virus S RNA. Total RNA was extracted from suckling mouse brain homogenate using guanidinium isothiocyanate (Chomczynski & Sacchi, 1987) . Primers for reverse transcription and PCR (EH9, CS 16 and CS 19) were as previously described . Primers F2 and R3 had sequences 5' TGGACACCTTCACAAACTC 3' and 5' GACAAATTCCCTGC-ACCA 3' respectively.
Sequence analysis of cloned cDNA. PCR products were gel-purified and cloned into the pBS vector essentially as described previously Expression of fusion proteins in Escherichia coli. Three subclones of the S RNA segment were amplified by PCR from the appropriate plasmid such that BamHI and EcoRI sites were introduced at either end, using the following primers: CS5B, 5' GCGGATCCCCTTTGA-AATTCAAAAAACAGG 3'; CS6E, 5' GCGAATTCAGATGATGT-TGGCACTGG 3'; CS7B, 5' GCGGATCCACAAAATCGAGGTGA-ACAGC 3'; CS9E, 5' GCGAATTCAGATGCATATATAGAGTCC-TT 3'; CSIOB, 5' GCGGATCCTTGTCGCAACCGGTCTTGCC 3'; CS11E, 5' GCGAATTCGTTCTTGTAGAGTTCCTGAGC 3". PCR products were cleaved with BamHI and EcoRI and ligated into plasmid pGEX-3X (Smith & Johnson, 1988) . Fusion proteins were induced and the soluble proteins were purified by glutathione-agarose affinity chromatography as described by Smith & Johnson (1988) .
ELISA. Bacteria-derived antigens were purified as described above, and purified glutathione S-transferase (GST) from pGEX-3X served as the negative control. Baculovirus-expressed N protein was purified from insect cell lysates by ammonium sulphate precipitation, desalting on Bio-Gel P-10 and anion-exchange chromatography using QSepharose Fast Flow. ELISA plates (Dynatech 96-well) were coated with antigen in the presence of bicarbonate buffer pH 9-6 at 4 °C. Plates were blocked with PBS containing 0.05 % Tween 20, 1 mM-EDTA and 0.25 % BSA. Antibody and conjugates were applied in the same buffer. Peroxidase conjugates (Sigma) were detected using o-phenylenediamine and hydrogen peroxide for 30 min. Reactions were stopped by adding HCI to a concentration of 1 M, and the A49 o was read using a Dynatech MicroEL1SA plate reader.
Results

Sequence determination of the S RNA and N protein of CCHF virus isolate AP92
The complete sequence of the S RNA of the Greek CCHF virus isolate AP92 was determined from three overlapping PCR products, comprising nucleotides 1 to 670 (CE26), 135 to 670 and 135 to 1659 (CF18). Based on these data it was deduced that the full-length RNA comprises 1659 nucleotides and contains a single open reading frame corresponding to a protein of 482 amino acids (54.2K). A multiple alignment of this protein sequence with known nairovirus N protein sequences is shown in Fig. 1, demonstrating that KKGNGLVDTF TNSYSFCENV PNLDRFVYOM ********N* *EM******* ********** **P*****S* ***E***F** *****VAST* EEF*T*YKQ* AEKHK*NNKY *E*A***AEI *Q**TYK*K* ***Q*KA*N* KEFDE**RP* SEKLQ*RSNL ***A'L'DR* *D*ALAEMI<* 51 i00 ASATDDAOKD SIYA~ALVEA TKYCAPIYEC AWVSSTGIVK KGLEWFEKN. ********** ********** **F******* ********** *********-EL*ST*NER* A**S***I** *RF****M** **A*C**T** R*****D**K
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LLSTPMI<WGK KHYELFADDS FQQN-RIYMHP AVLTAGRISE MGVCFGTIPV C68031 ********** *L******** ********** ********** ********** HAZ *INS*L **** RLI*****ND *TE******* C***S**M** L*IS**AV** DUG *T***LR*** GLIN*****D *LG**L**** ****P**M** **A***V*** 401 450 AP92 ANPDDAAQGS GHTKSILNLR TNTESNNPCA RTIVKLFEIO KTGFDIKDMD C68031 ********** ********** ****T***** K*****[**** ****N'Q*** HAZ TS******** ****AV**YK *K**VG**** CI*SS***** *A*Y**ES** DUG *S*E**IL** **S*N***FK ID*SVQ**** S***Q*IQNP EIWL ...... Sf21 cells with linearized bacPAK6 DNA. Selection of polyhedrin-negative, fl-galactosidase-negative plaques, followed by further rounds of plaque purification, led to the recovery of recombinant virus AcC4. The recombinant virus expressed high levels of a 54K protein by 48 h post-infection (Fig. 2) . This protein was shown to be the CCHF virus N protein by immunoblotting with a monoclonal antibody specific for the N protein of CCHF virus C68031 (Fig. 2, lane 4) . AcC4-expressed N protein was partially purified from cell lysates by ammonium sulphate precipitation. The material precipitated between 40 % and 70 % saturation was collected and was used to immunize guinea-pigs. The resulting antiserum was used in subsequent assays.
451
Expression of CCHF virus N-derived peptides in E. coli
Since previous work showed cross-reactivity between CCHF, DUG and HAZ virus N proteins, we expressed short (50 to 60 residue) sequences in an attempt to reduce the cross-reactions. Three regions of the N sequence were chosen, based on sequences that are conserved in the two reported CCHF virus sequences, but not in the HAZ and DUG virus N sequences (Fig. 1) . The similarities between these three peptides and the corresponding regions of HAZ and DUG virus N proteins are shown in Table 1 . The CCHF virus peptides were expressed as GST fusion proteins by cloning the appropriate PCR products into the pGEX-3X vector. Primers CS5B and CS6E generated fusion vector XC9 (note that although XC9 was amplified from CCHF virus C68031 cDNA rather than AP92, there are only two amino acid differences between the corresponding sequences in this region). CS7B and CS9E generated vector XD13, and CS10B and CSllE generated vector XE8. Proteins were induced with IPTG and the products were purified using glutathione-agarose affinity chromatography.
Optimiziation of ELISA for detection of anti-CCHF virus antibodies
The antigens employed for ELISA were the purified fusion peptides, or AcC4-derived N protein purified by ammonium sulphate fractionation followed by ionexchange on Q-Sepharose Fast Flow (this resulted in a yield of less than 10 % but purity of greater than 90 %). Control antigens were purified GST, or a 40 to 70 % ammonium sulphate fraction of an uninfected Sf21 cell lysate, used at the same concentration as the corresponding positive antigen. In every case, the A490 value obtained with control antigen was subtracted from the A490 value obtained with the corresponding virus-derived antigens before further analysis. Using the guinea-pig anti-AcC4 serum the amount of antigen was titrated in the range 13 to 500 ng/well and the optimum A490 w a s obtained with 200 ng/well for all four antigens. Peptide XE8 and full-length N protein from AcC4 gave the highest A~90 values for all antibody dilutions tested, whereas XC9 gave very low values (data not shown). A 1 : 200 dilution was chosen as giving the optimum signal to background ratio for the various sera. An antiserum was judged positive if the difference in A490 between positive and negative antigens was greater than three s.D.s above the mean difference in A4~ 0 of a panel of known negative sera derived fi'om the same species.
Screening of human and laboratory animal sera by ELISA
The specificity of ELISA was determined using laboratory animal sera raised against a range of nairoviruses (Table 2) . Sera against the Greek AP92 and Nigerian IbAr 10200 isolates of CCHF virus gave positive reactions with XE8 and AcC4 antigens. XD13 and XC9 Table 2. antigens did not detect antibodies in any of the sera. Antibodies against DUG and HAZ viruses were not detected, whereas both were positive using expressed DUG N antigen (Ward et al., 1992) , indicating that this ELISA using CCHF virus N antigens has a higher specificity for CCHF virus. Antibodies that recognized representatives of the other nairovirus serogroups were not detected.
The results with human antisera are shown in Table 3 .
Six of eight sera reacted with XE8 and with AcC4. Taken together these two antigens reacted with seven of eight sera tested. Although XD13 and XC9 were clearly less antigenic than XE8 and AcC4, antibodies that reacted with XD13 were detected in a serum from Senegal and antibodies that reacted with both XD13 and XC9 were detected in a serum from Albania. The sera from Pakistan, Saudi Arabia and Albania all came from viral haemorrhagic fever cases, whereas the Senegalese and four Greek sera were from inapparent infections and were collected during serological surveys using CCHF IbAr 10200 as the ELISA antigen . The Greek serum Ki, which was negative using our assay, had the lowest ELISA titre of this batch of sera and may have lost its reactivity because of freezing and thawing. Under the conditions described in this paper, none of the sera tested were positive in an ELISA using the DUG N antigen.
Discussion
We describe here the first sequence data for a European CCHF virus isolate, AP92, from northern Greece. AP92 virus is clearly more closely related to a Chinese CCHF virus isolate than to DUG and HAZ viruses. Furthermore, we have expressed the N protein and Nderived peptides from the cDNA of the Greek isolate and shown that two of these products have the potential to detect antibodies in human sera from Europe, the Middle East, Asia and West Africa. The ELISA developed was shown to be specific for CCHF virus-induced IgG and did not show cross-reactivity with antibodies to non-CCHF nairoviruses, which we have shown to be comparatively common in some human populations . Although the full-length N protein did not detect antibodies in two positive sera, the XE8 antigen detected antibodies in one of these sera. This indicates that some human IgGs to CCHF virus N protein are directed to epitopes that are not conformationally available in native protein derived from AP92. Two other peptides, XD13 from the aminoterminal region of the N protein and XC9 from the carboxy terminus, detected antibodies in sera from Senegal and Albania, indicating that the immune response to the N protein can vary between infected individuals. These latter two peptides were not detected by antisera from guinea-pigs immunized with native N protein, or from mice immunized with live AP92 or IbAr 10200 CCHF viruses. There was no correlation between the type of response of the human sera and the clinical symptoms of the subject (haemorrhagic fever or inapparent infection). However, larger studies would be required to reveal any significant variations in human immune response to CCHF virus N protein. We propose that a combination of antigens AcC4 and XE8 will be useful in diagnosis of CCHF virus infection in serological surveys, both in Europe and Africa, that are currently in progress.
